Background: The National Health Service Health Check program in England is the largest cardiovascular risk assessment and management program in the world. We assessed the effect of this program on modelled risk of cardio-vascular disease, individual risk factors for cardiovascular disease, prescribing of relevant medications and diagnosis of vascular disease. Methods: We obtained retrospective electronic medical records for a randomly selected sample of 138 788 patients aged 40-74 years registered with 462 English general practices participating in the Clinical Practice Research Datalink between 2009 and 2013. We used a quasi-experimental design of difference-indifferences matching analysis to compare changes in outcomes between Health Check attendees and nonattendees, with a median follow-up time of 2 years. Results: Overall, 21.4% of the eligible population attended a Health Check. After matching (n = 29 672 in each group), attendees had a significant absolute reduction in modelled risk for cardiovascular disease (-0.21%, 95% confidence interval [CI] -0.24% to -0.19%) and individual risk factors: systolic blood pressure (-2.51 mm Hg, 95% CI -2.77 to -2.25 mm Hg), diastolic blood pressure (-1.46 mm Hg, 95% CI -1.62 to -1.29 mm Hg), body mass index (-0.27, 95% CI -0.34 to -0.20) and total cholesterol (-0.15 mmol/L, 95% CI -0.18 to -0.13 mmol/L). Statins were prescribed for 39.9% of attendees who were at high risk for cardiovascular disease. The program resulted in significantly more diagnoses of selected vascular diseases among attendees, with the largest increases for hypertension (2.99%) and type 2 diabetes mellitus (1.31%). Interpretation: The National Health Service Health Check program had statistically significant but clinically modest impacts on modelled risk for cardiovascular disease and individual risk factors, although diagnosis of vascular disease increased. Overall program performance was substantially below national and international targets, which highlights the need for careful planning, monitoring and evaluation of similar initiatives internationally.
机构:
Purdue Univ, Ctr Hlth Outcomes Res & Policy, Regenstrief Ctr Healthcare Engn, W Lafayette, IN 47907 USAPurdue Univ, Coll Pharm, Dept Pharm Practice, Ctr Hlth Outcomes Res & Policy, W Lafayette, IN 47907 USA
Menon, Jyothi
Paulet, Mindy
论文数: 0引用数: 0
h-index: 0
机构:
Purdue Univ, WorkLife Programs Human Resources, W Lafayette, IN 47907 USAPurdue Univ, Coll Pharm, Dept Pharm Practice, Ctr Hlth Outcomes Res & Policy, W Lafayette, IN 47907 USA
Paulet, Mindy
Thomas, Joseph, III
论文数: 0引用数: 0
h-index: 0
机构:
Purdue Univ, Coll Pharm, Dept Pharm Practice, Ctr Hlth Outcomes Res & Policy, W Lafayette, IN 47907 USA
Purdue Univ, Ctr Hlth Outcomes Res & Policy, Regenstrief Ctr Healthcare Engn, W Lafayette, IN 47907 USAPurdue Univ, Coll Pharm, Dept Pharm Practice, Ctr Hlth Outcomes Res & Policy, W Lafayette, IN 47907 USA
机构:
Univ London Imperial Coll Sci Technol & Med, Fac Med, London W6 8RP, England
NHS Ealing, Southall, Middx, EnglandUniv London Imperial Coll Sci Technol & Med, Fac Med, London W6 8RP, England
Dalton, Andrew R. H.
Soljak, Michael
论文数: 0引用数: 0
h-index: 0
机构:
Univ London Imperial Coll Sci Technol & Med, Fac Med, London W6 8RP, EnglandUniv London Imperial Coll Sci Technol & Med, Fac Med, London W6 8RP, England
Soljak, Michael
Samarasundera, Edgar
论文数: 0引用数: 0
h-index: 0
机构:
Univ London Imperial Coll Sci Technol & Med, Fac Med, London W6 8RP, EnglandUniv London Imperial Coll Sci Technol & Med, Fac Med, London W6 8RP, England
Samarasundera, Edgar
Millett, Christopher
论文数: 0引用数: 0
h-index: 0
机构:
Univ London Imperial Coll Sci Technol & Med, Fac Med, London W6 8RP, EnglandUniv London Imperial Coll Sci Technol & Med, Fac Med, London W6 8RP, England
Millett, Christopher
Majeed, Azeem
论文数: 0引用数: 0
h-index: 0
机构:
Univ London Imperial Coll Sci Technol & Med, Fac Med, London W6 8RP, EnglandUniv London Imperial Coll Sci Technol & Med, Fac Med, London W6 8RP, England